Major Global Killer Tamed by Hydrogen

por Barry, Clifton E.
Publicado 2015

Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses

por Lenaerts, Anne, Barry, Clifton E, Dartois, Véronique
Publicado 2015

Signature required: The transcriptional response to tuberculosis

por Barry, Clifton E., Mayer-Barber, Katrin D.
Publicado 2021

Treatments of Multidrug-Resistant Tuberculosis: Light at the End of the Tunnel

por Lange, Christoph, Barry, Clifton E., Horsburgh, C. Robert
Publicado 2022

Tuberculosis Drug Discovery: A Decade of Hit Assessment for Defined Targets

por Oh, Sangmi, Trifonov, Lena, Yadav, Veena D., Barry, Clifton E., Boshoff, Helena I.
Publicado 2021

Fumarate Reductase Activity Maintains an Energized Membrane in Anaerobic Mycobacterium tuberculosis

por Watanabe, Shinya, Zimmermann, Michael, Goodwin, Michael B., Sauer, Uwe, Barry, Clifton E., Boshoff, Helena I.
Publicado 2011

MAIT cell-directed therapy of Mycobacterium tuberculosis infection

por Sakai, Shunsuke, Kauffman, Keith D., Oh, Sangmi, Nelson, Christine E., Barry, Clifton E., Barber, Daniel L.
Publicado 2020

Rv2607 from Mycobacterium tuberculosis Is a Pyridoxine 5′-Phosphate Oxidase with Unusual Substrate Specificity

por Mashalidis, Ellene H., Mukherjee, Tathagata, Śledź, Paweł, Matak-Vinković, Dijana, Boshoff, Helena, Abell, Chris, Barry, Clifton E.
Publicado 2011

Comparative Evaluation of Sloppy Molecular Beacon and Dual-Labeled Probe Melting Temperature Assays to Identify Mutations in Mycobacterium tuberculosis Resulting in Rifampin, Fluor...

por Roh, Sandy S., Smith, Laura E., Lee, Jong Seok, Via, Laura E., Barry, Clifton E., Alland, David, Chakravorty, Soumitesh
Publicado 2015

Synthesis and Structure–Activity Relationships of a New Class of Oxadiazoles Targeting DprE1 as Antitubercular Agents

por Yadav, Veena D., Boshoff, Helena I., Trifonov, Lena, Roma, Jose Santinni O., Ioerger, Thomas R., Barry, Clifton E., Oh, Sangmi
Publicado 2023

A novel F(420)-dependent anti-oxidant mechanism protects Mycobacterium tuberculosis against oxidative stress and bactericidal agents

por Gurumurthy, Meera, Rao, Martin, Mukherjee, Tathagata, Rao, Srinivasa P S, Boshoff, Helena I, Dick, Thomas, Barry, Clifton E, Manjunatha, Ujjini H
Publicado 2013

Extreme Drug Tolerance of Mycobacterium tuberculosis in Caseum

por Sarathy, Jansy P., Via, Laura E., Weiner, Danielle, Blanc, Landry, Boshoff, Helena, Eugenin, Eliseo A., Barry, Clifton E., Dartois, Véronique A.
Publicado 2018

Phylogenomic analysis of the diversity of graspetides and proteins involved in their biosynthesis

por Makarova, Kira S., Blackburne, Brittney, Wolf, Yuri I., Nikolskaya, Anastasia, Karamycheva, Svetlana, Espinoza, Marlene, Barry, Clifton E., Bewley, Carole A., Koonin, Eugene V.
Publicado 2022

Validation of CoaBC as a Bactericidal Target in the Coenzyme A Pathway of Mycobacterium tuberculosis

por Evans, Joanna C., Trujillo, Carolina, Wang, Zhe, Eoh, Hyungjin, Ehrt, Sabine, Schnappinger, Dirk, Boshoff, Helena I. M., Rhee, Kyu Y., Barry, Clifton E., Mizrahi, Valerie
Publicado 2016

Within patient microevolution of Mycobacterium tuberculosis correlates with heterogeneous responses to treatment

por Liu, Qingyun, Via, Laura E., Luo, Tao, Liang, Lili, Liu, Xin, Wu, Sufang, Shen, Qingyu, Wei, Wang, Ruan, Xianglin, Yuan, Xing, Zhang, Guolong, Barry, Clifton E., Gao, Qian
Publicado 2015

Evaluating the Sensitivity of Mycobacterium tuberculosis to Biotin Deprivation Using Regulated Gene Expression

por Woong Park, Sae, Klotzsche, Marcus, Wilson, Daniel J., Boshoff, Helena I., Eoh, Hyungjin, Manjunatha, Ujjini, Blumenthal, Antje, Rhee, Kyu, Barry, Clifton E., Aldrich, Courtney C., Ehrt, Sabine, Schnappinger, Dirk
Publicado 2011

Fragment-Sized EthR Inhibitors Exhibit Exceptionally Strong Ethionamide Boosting Effect in Whole-Cell Mycobacterium tuberculosis Assays

por Nikiforov, Petar O., Blaszczyk, Michal, Surade, Sachin, Boshoff, Helena I., Sajid, Andaleeb, Delorme, Vincent, Deboosere, Nathalie, Brodin, Priscille, Baulard, Alain R., Barry, Clifton E., Blundell, Tom L., Abell, Chris
Publicado 2017

Tuberculosis drugs’ distribution and emergence of resistance in patient’s lung lesions: A mechanistic model and tool for regimen and dose optimization

por Strydom, Natasha, Gupta, Sneha V., Fox, William S., Via, Laura E., Bang, Hyeeun, Lee, Myungsun, Eum, Seokyong, Shim, TaeSun, Barry, Clifton E., Zimmerman, Matthew, Dartois, Véronique, Savic, Radojka M.
Publicado 2019

Pharmacological Inhibition of Host Heme Oxygenase-1 Suppresses Mycobacterium tuberculosis Infection In Vivo by a Mechanism Dependent on T Lymphocytes

por Costa, Diego L., Namasivayam, Sivaranjani, Amaral, Eduardo P., Arora, Kriti, Chao, Alex, Mittereder, Lara R., Maiga, Mamoudou, Boshoff, Helena I., Barry, Clifton E., Goulding, Celia W., Andrade, Bruno B., Sher, Alan
Publicado 2016

Bacterial Loads Measured by the Xpert MTB/RIF Assay as Markers of Culture Conversion and Bacteriological Cure in Pulmonary TB

por Shenai, Shubhada, Ronacher, Katharina, Malherbe, Stefanus, Stanley, Kim, Kriel, Magdalena, Winter, Jill, Peppard, Thomas, Barry, Charles E., Wang, Jing, Dodd, Lori E., Via, Laura E., Barry, Clifton E., Walzl, Gerhard, Alland, David
Publicado 2016